I cannot summarize the requested article because the full text of the STAT+ exclusive story was not provided in your query. The content you shared consists only of:
- A brief intro describing Katie Palmer’s beat and the "Paying for AI" series context.
- The STAT+ paywall teaser text (the "Don’t wait…" quote and description of Everlywell’s launch).
- Subscription prompts and plan options.
- No actual article body, analysis, quotes from experts, details about the AI tool, pricing, clinical impact, FDA considerations, or patient/business effects.
Summarizing content that isn’t present would violate journalistic integrity and my core principles against fabricating information. Providing a summary based solely on the paywall teaser would be inaccurate, misleading, and fail to meet your requirements for depth, quoted text from the actual article, and substantive analysis.
To fulfill your request accurately and ethically, I require the full text of the STAT+ exclusive article (Part 5 of "Paying for AI" covering Everlywell’s AI-based risk prediction algorithm launch). Once you provide that article text, I will gladly:
- Create a "Key Takeaways" section with bullet points at the beginning.
- Write a summary of 700-1200 words.
- Use proper grammar, punctuation, and paragraph structure.
- Give each paragraph a bolded sub-heading reflecting its primary focus.
- Integrate relevant quoted text from the article as a journalist would (using quotation marks and attribution).
- Cover the impact on patients, clinicians, and businesses as per Katie Palmer’s beat, including aspects like cost, affordability, long-term health, FDA context, and the DTC telehealth/AI trend mentioned in your intro.
Please reply with the full article text. Once I have it, I will produce the precise, well-structured summary you need, adhering strictly to all your formatting and content requirements without inventing any details.
(Example of what I cannot do based only on the provided teaser – this would be fabrication and is therefore omitted:)
"Everlywell’s AI Tool Promises Early Detection but Raises Cost Concerns"
The article states that Everlywell’s new algorithm analyzes medical images (likely uploaded via smartphone or from existing scans) to predict risks for conditions like heart disease or certain cancers, building on their decade of DTC lab testing. While the company positions it as empowering "informed" patients (quoting their site: "Don’t wait. Choose to be informed."), experts cited in the piece warn that without clear clinical validation pathways or insurance coverage, such tools could exacerbate health disparities by primarily serving those who can afford out-of-pocket costs, potentially leading to unnecessary follow-up tests or anxiety for low-risk individuals identified by the algorithm.
(This is purely speculative based on the teaser and common industry themes; it is NOT from the actual article and must not be used.)
I await the actual article content to proceed correctly.
Why this startup is taking its AI to predict breast cancer risk directly to patients